Filters

See more specimen types...

Other countries

Results: 1 to 20 of 44 (representing 16 labs)

Tests names and labsConditionsGenes and analytesMethods

FoundationOne®

Foundation Medicine, Inc.
United States
1315
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region

Pleuropulmonary blastoma

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

BrainTumorNext

Ambry Genetics
United States
7727
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CustomNext-Cancer

Ambry Genetics
United States
6867
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Cancer Sequencing and Deletion/Duplication Panel

PreventionGenetics
United States
4335
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

DICER1 Syndrome via the DICER1 Gene

PreventionGenetics
United States
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Pleuropulmonary Blastoma (PPB) Family Tumor and Dysplasia Syndrome, DICER1 Syndrome

Ambry Genetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Renal cell carcinoma

Institute of Human Genetics Cologne University
Germany
111
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Thyroid Cancer

Asper Biotech Asper Biotech Ltd.
Estonia
1010
  • C Sequence analysis of the entire coding region

Hereditary Thyroid Cancer Panel

Genetic Services Laboratory University of Chicago
United States
1012
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Hereditary Cancer Panel

Blueprint Genetics
Finland
14116
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Pediatric Cancer Panel

Blueprint Genetics
Finland
652
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Renal Cancer Panel

Blueprint Genetics
Finland
425
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Breast and Ovarian Cancer Panel

Blueprint Genetics
Finland
122
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Thyroid Cancer Panel

Blueprint Genetics
Finland
111
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Endocrine Cancer Panel

Blueprint Genetics
Finland
622
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Hereditary Cancer Syndromes - panels

Medizinisch Genetisches Zentrum München MGZ München
Germany
6100
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Pediatric Solid Tumors Panel

Invitae
United States
9148
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Invitae Pediatric Nervous System/Brain Tumors Panel

Invitae
United States
3024
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Renal / Urinary Cancer Comprehensive Panel

Fulgent Genetics
United States
77327
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 44

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center